<p>If we restrict our set of patients to those with partial response (n = 24) and progressive disease (n = 37), a significant relationship between miR-345 expression and response to therapy was obtained with an odds ratio of 5.37, (<i>P</i>-value = 0.004 and 95% CI: 1.56–20.94).</p
<p>Light gray boxes indicate upregulated miRNAs. Dark grey boxes indicate downregulated/no change/un...
<p>A: Patients were labeled according to PFI as refractory (PFI <6 months), resistant (PFI 6-12 mont...
<p>(A) Positive correlation of log2 normalized expression of miR-342 detected on miRNA arrays and lo...
<p>Patients were dichotomized by low miR-345 expression (red) and high miR-345 expression (blue). (<...
<p>(<b>A</b>) Patients were dichotomized by <i>KRAS</i> mutation status and miR-345. (<b>B</b>) Pati...
<p>(A) The set of patients is assigned to different cohorts according to contribution, or lack of, t...
<p>The first and second set of patients (series A and B, n = 66) were grouped. <i>P</i> values are f...
<p>The box represents the 25%-75% percentiles; the line inside the box represents the median and the...
<p>Relationship between miR-338-3p expression level and clinicopathologic variables in 66 GC patient...
<p>Expression levels of <b>(A)</b> miR-17-5p, <b>(B)</b> miR-20a-5p, <b>(C)</b> miR-30a-5p, <b>(D)</...
<p>(A) Quantification (Ct) of candidate reference miRNAs (miR-192, miR-16, and miR-93) in serum samp...
<p>Box plots of plasma levels of miR-601(A) and miR-760(B) in normal subjects (n = 58), advanced ade...
<p>Relative expression of miR-103 in the cellular fraction of human peripheral blood of malignant me...
<p>Patients were dichotomized by the median expression value for miR-345. Low miRNA expression (red)...
<p><b>A</b>. Therapeutic response according to miR-148a expression. Complete response, CR; partial r...
<p>Light gray boxes indicate upregulated miRNAs. Dark grey boxes indicate downregulated/no change/un...
<p>A: Patients were labeled according to PFI as refractory (PFI <6 months), resistant (PFI 6-12 mont...
<p>(A) Positive correlation of log2 normalized expression of miR-342 detected on miRNA arrays and lo...
<p>Patients were dichotomized by low miR-345 expression (red) and high miR-345 expression (blue). (<...
<p>(<b>A</b>) Patients were dichotomized by <i>KRAS</i> mutation status and miR-345. (<b>B</b>) Pati...
<p>(A) The set of patients is assigned to different cohorts according to contribution, or lack of, t...
<p>The first and second set of patients (series A and B, n = 66) were grouped. <i>P</i> values are f...
<p>The box represents the 25%-75% percentiles; the line inside the box represents the median and the...
<p>Relationship between miR-338-3p expression level and clinicopathologic variables in 66 GC patient...
<p>Expression levels of <b>(A)</b> miR-17-5p, <b>(B)</b> miR-20a-5p, <b>(C)</b> miR-30a-5p, <b>(D)</...
<p>(A) Quantification (Ct) of candidate reference miRNAs (miR-192, miR-16, and miR-93) in serum samp...
<p>Box plots of plasma levels of miR-601(A) and miR-760(B) in normal subjects (n = 58), advanced ade...
<p>Relative expression of miR-103 in the cellular fraction of human peripheral blood of malignant me...
<p>Patients were dichotomized by the median expression value for miR-345. Low miRNA expression (red)...
<p><b>A</b>. Therapeutic response according to miR-148a expression. Complete response, CR; partial r...
<p>Light gray boxes indicate upregulated miRNAs. Dark grey boxes indicate downregulated/no change/un...
<p>A: Patients were labeled according to PFI as refractory (PFI <6 months), resistant (PFI 6-12 mont...
<p>(A) Positive correlation of log2 normalized expression of miR-342 detected on miRNA arrays and lo...